nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—esophageal cancer	0.383	0.566	CbGaD
Ifosfamide—PTGS1—esophageal cancer	0.293	0.434	CbGaD
Ifosfamide—CYP2C9—Capecitabine—esophageal cancer	0.0176	0.407	CbGbCtD
Ifosfamide—CYP2B6—Cisplatin—esophageal cancer	0.0168	0.388	CbGbCtD
Ifosfamide—CYP2C9—Cisplatin—esophageal cancer	0.00887	0.205	CbGbCtD
Ifosfamide—Cyclophosphamide—CYP2A6—esophageal cancer	0.00306	0.729	CrCbGaD
Ifosfamide—Cyclophosphamide—ABCB1—esophageal cancer	0.00114	0.271	CrCbGaD
Ifosfamide—Hepatic failure—Capecitabine—esophageal cancer	0.000347	0.002	CcSEcCtD
Ifosfamide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000346	0.00199	CcSEcCtD
Ifosfamide—Dysarthria—Methotrexate—esophageal cancer	0.000338	0.00195	CcSEcCtD
Ifosfamide—Renal failure acute—Capecitabine—esophageal cancer	0.000338	0.00195	CcSEcCtD
Ifosfamide—Amnesia—Capecitabine—esophageal cancer	0.000332	0.00191	CcSEcCtD
Ifosfamide—Inflammation—Methotrexate—esophageal cancer	0.00033	0.0019	CcSEcCtD
Ifosfamide—Atrial fibrillation—Capecitabine—esophageal cancer	0.000329	0.0019	CcSEcCtD
Ifosfamide—Renal impairment—Capecitabine—esophageal cancer	0.000328	0.00189	CcSEcCtD
Ifosfamide—Vasculitis—Methotrexate—esophageal cancer	0.000328	0.00189	CcSEcCtD
Ifosfamide—Respiratory failure—Methotrexate—esophageal cancer	0.000326	0.00188	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000322	0.00185	CcSEcCtD
Ifosfamide—Renal failure—Cisplatin—esophageal cancer	0.000321	0.00185	CcSEcCtD
Ifosfamide—Pulmonary embolism—Methotrexate—esophageal cancer	0.00032	0.00184	CcSEcCtD
Ifosfamide—Myocardial infarction—Cisplatin—esophageal cancer	0.00032	0.00184	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00032	0.00184	CcSEcCtD
Ifosfamide—Cardiac failure—Capecitabine—esophageal cancer	0.00032	0.00184	CcSEcCtD
Ifosfamide—Stomatitis—Cisplatin—esophageal cancer	0.000318	0.00183	CcSEcCtD
Ifosfamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000317	0.00183	CcSEcCtD
Ifosfamide—Pain in extremity—Capecitabine—esophageal cancer	0.000312	0.0018	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000312	0.0018	CcSEcCtD
Ifosfamide—Osteoarthritis—Capecitabine—esophageal cancer	0.000312	0.0018	CcSEcCtD
Ifosfamide—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000309	0.00178	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000309	0.00178	CcSEcCtD
Ifosfamide—Skin exfoliation—Methotrexate—esophageal cancer	0.000305	0.00176	CcSEcCtD
Ifosfamide—Bradycardia—Cisplatin—esophageal cancer	0.000298	0.00172	CcSEcCtD
Ifosfamide—Cardiac arrest—Capecitabine—esophageal cancer	0.000297	0.00171	CcSEcCtD
Ifosfamide—Urinary retention—Capecitabine—esophageal cancer	0.000297	0.00171	CcSEcCtD
Ifosfamide—Coma—Methotrexate—esophageal cancer	0.000292	0.00168	CcSEcCtD
Ifosfamide—Blood creatinine increased—Capecitabine—esophageal cancer	0.000292	0.00168	CcSEcCtD
Ifosfamide—Neoplasm—Methotrexate—esophageal cancer	0.000289	0.00167	CcSEcCtD
Ifosfamide—Urine output increased—Methotrexate—esophageal cancer	0.000289	0.00167	CcSEcCtD
Ifosfamide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000289	0.00167	CcSEcCtD
Ifosfamide—Connective tissue disorder—Cisplatin—esophageal cancer	0.000288	0.00166	CcSEcCtD
Ifosfamide—Urethral disorder—Cisplatin—esophageal cancer	0.000287	0.00165	CcSEcCtD
Ifosfamide—Pulmonary oedema—Methotrexate—esophageal cancer	0.000285	0.00164	CcSEcCtD
Ifosfamide—Hypokalaemia—Capecitabine—esophageal cancer	0.000284	0.00164	CcSEcCtD
Ifosfamide—Visual impairment—Cisplatin—esophageal cancer	0.000282	0.00162	CcSEcCtD
Ifosfamide—Breast disorder—Capecitabine—esophageal cancer	0.000282	0.00162	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000281	0.00162	CcSEcCtD
Ifosfamide—Sepsis—Methotrexate—esophageal cancer	0.000278	0.0016	CcSEcCtD
Ifosfamide—Eye disorder—Cisplatin—esophageal cancer	0.000274	0.00158	CcSEcCtD
Ifosfamide—Tinnitus—Cisplatin—esophageal cancer	0.000273	0.00157	CcSEcCtD
Ifosfamide—Cardiac disorder—Cisplatin—esophageal cancer	0.000272	0.00156	CcSEcCtD
Ifosfamide—Flushing—Cisplatin—esophageal cancer	0.000272	0.00156	CcSEcCtD
Ifosfamide—Thrombophlebitis—Methotrexate—esophageal cancer	0.000268	0.00155	CcSEcCtD
Ifosfamide—Bronchospasm—Capecitabine—esophageal cancer	0.000265	0.00153	CcSEcCtD
Ifosfamide—Polyuria—Methotrexate—esophageal cancer	0.000265	0.00152	CcSEcCtD
Ifosfamide—Immune system disorder—Cisplatin—esophageal cancer	0.000265	0.00152	CcSEcCtD
Ifosfamide—Mediastinal disorder—Cisplatin—esophageal cancer	0.000264	0.00152	CcSEcCtD
Ifosfamide—Angina pectoris—Capecitabine—esophageal cancer	0.000263	0.00151	CcSEcCtD
Ifosfamide—Arrhythmia—Cisplatin—esophageal cancer	0.000262	0.00151	CcSEcCtD
Ifosfamide—Alopecia—Cisplatin—esophageal cancer	0.000259	0.00149	CcSEcCtD
Ifosfamide—Hepatic failure—Methotrexate—esophageal cancer	0.000258	0.00149	CcSEcCtD
Ifosfamide—Pancytopenia—Capecitabine—esophageal cancer	0.000256	0.00147	CcSEcCtD
Ifosfamide—Malnutrition—Cisplatin—esophageal cancer	0.000255	0.00147	CcSEcCtD
Ifosfamide—Erythema—Cisplatin—esophageal cancer	0.000255	0.00147	CcSEcCtD
Ifosfamide—Dysuria—Capecitabine—esophageal cancer	0.000252	0.00145	CcSEcCtD
Ifosfamide—Renal failure acute—Methotrexate—esophageal cancer	0.000252	0.00145	CcSEcCtD
Ifosfamide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000243	0.0014	CcSEcCtD
Ifosfamide—Pneumonia—Capecitabine—esophageal cancer	0.000242	0.00139	CcSEcCtD
Ifosfamide—Infestation NOS—Capecitabine—esophageal cancer	0.00024	0.00138	CcSEcCtD
Ifosfamide—Infestation—Capecitabine—esophageal cancer	0.00024	0.00138	CcSEcCtD
Ifosfamide—Vision blurred—Cisplatin—esophageal cancer	0.00024	0.00138	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000238	0.00137	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000237	0.00136	CcSEcCtD
Ifosfamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000237	0.00136	CcSEcCtD
Ifosfamide—Renal failure—Capecitabine—esophageal cancer	0.000236	0.00136	CcSEcCtD
Ifosfamide—Myocardial infarction—Capecitabine—esophageal cancer	0.000236	0.00136	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000236	0.00136	CcSEcCtD
Ifosfamide—Anaemia—Cisplatin—esophageal cancer	0.000236	0.00136	CcSEcCtD
Ifosfamide—Stomatitis—Capecitabine—esophageal cancer	0.000234	0.00135	CcSEcCtD
Ifosfamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000234	0.00135	CcSEcCtD
Ifosfamide—Osteoarthritis—Methotrexate—esophageal cancer	0.000232	0.00134	CcSEcCtD
Ifosfamide—Malaise—Cisplatin—esophageal cancer	0.00023	0.00132	CcSEcCtD
Ifosfamide—Haematuria—Capecitabine—esophageal cancer	0.000229	0.00132	CcSEcCtD
Ifosfamide—Leukopenia—Cisplatin—esophageal cancer	0.000228	0.00131	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000227	0.00131	CcSEcCtD
Ifosfamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000224	0.00129	CcSEcCtD
Ifosfamide—Convulsion—Cisplatin—esophageal cancer	0.000221	0.00127	CcSEcCtD
Ifosfamide—Bradycardia—Capecitabine—esophageal cancer	0.00022	0.00127	CcSEcCtD
Ifosfamide—Myalgia—Cisplatin—esophageal cancer	0.000217	0.00125	CcSEcCtD
Ifosfamide—Haemoglobin—Capecitabine—esophageal cancer	0.000217	0.00125	CcSEcCtD
Ifosfamide—Haemorrhage—Capecitabine—esophageal cancer	0.000216	0.00124	CcSEcCtD
Ifosfamide—Hepatitis—Capecitabine—esophageal cancer	0.000216	0.00124	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000216	0.00124	CcSEcCtD
Ifosfamide—Discomfort—Cisplatin—esophageal cancer	0.000214	0.00123	CcSEcCtD
Ifosfamide—Urinary tract disorder—Capecitabine—esophageal cancer	0.000213	0.00123	CcSEcCtD
Ifosfamide—Connective tissue disorder—Capecitabine—esophageal cancer	0.000212	0.00122	CcSEcCtD
Ifosfamide—Urethral disorder—Capecitabine—esophageal cancer	0.000212	0.00122	CcSEcCtD
Ifosfamide—Breast disorder—Methotrexate—esophageal cancer	0.00021	0.00121	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000209	0.0012	CcSEcCtD
Ifosfamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000208	0.0012	CcSEcCtD
Ifosfamide—Oedema—Cisplatin—esophageal cancer	0.000208	0.0012	CcSEcCtD
Ifosfamide—Visual impairment—Capecitabine—esophageal cancer	0.000208	0.0012	CcSEcCtD
Ifosfamide—Infection—Cisplatin—esophageal cancer	0.000207	0.00119	CcSEcCtD
Ifosfamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000204	0.00118	CcSEcCtD
Ifosfamide—Nervous system disorder—Cisplatin—esophageal cancer	0.000204	0.00117	CcSEcCtD
Ifosfamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000204	0.00117	CcSEcCtD
Ifosfamide—Skin disorder—Cisplatin—esophageal cancer	0.000202	0.00116	CcSEcCtD
Ifosfamide—Eye disorder—Capecitabine—esophageal cancer	0.000202	0.00116	CcSEcCtD
Ifosfamide—Tinnitus—Capecitabine—esophageal cancer	0.000201	0.00116	CcSEcCtD
Ifosfamide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000201	0.00116	CcSEcCtD
Ifosfamide—Flushing—Capecitabine—esophageal cancer	0.0002	0.00115	CcSEcCtD
Ifosfamide—Cardiac disorder—Capecitabine—esophageal cancer	0.0002	0.00115	CcSEcCtD
Ifosfamide—Anorexia—Cisplatin—esophageal cancer	0.000198	0.00114	CcSEcCtD
Ifosfamide—Pancreatitis—Methotrexate—esophageal cancer	0.000197	0.00113	CcSEcCtD
Ifosfamide—Angiopathy—Capecitabine—esophageal cancer	0.000196	0.00113	CcSEcCtD
Ifosfamide—Immune system disorder—Capecitabine—esophageal cancer	0.000195	0.00112	CcSEcCtD
Ifosfamide—Mediastinal disorder—Capecitabine—esophageal cancer	0.000195	0.00112	CcSEcCtD
Ifosfamide—Hypotension—Cisplatin—esophageal cancer	0.000194	0.00112	CcSEcCtD
Ifosfamide—Chills—Capecitabine—esophageal cancer	0.000194	0.00112	CcSEcCtD
Ifosfamide—Arrhythmia—Capecitabine—esophageal cancer	0.000193	0.00111	CcSEcCtD
Ifosfamide—Alopecia—Capecitabine—esophageal cancer	0.000191	0.0011	CcSEcCtD
Ifosfamide—Pancytopenia—Methotrexate—esophageal cancer	0.000191	0.0011	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00019	0.00109	CcSEcCtD
Ifosfamide—Mental disorder—Capecitabine—esophageal cancer	0.000189	0.00109	CcSEcCtD
Ifosfamide—Erythema—Capecitabine—esophageal cancer	0.000188	0.00108	CcSEcCtD
Ifosfamide—Malnutrition—Capecitabine—esophageal cancer	0.000188	0.00108	CcSEcCtD
Ifosfamide—Dysuria—Methotrexate—esophageal cancer	0.000188	0.00108	CcSEcCtD
Ifosfamide—Paraesthesia—Cisplatin—esophageal cancer	0.000187	0.00108	CcSEcCtD
Ifosfamide—Dyspnoea—Cisplatin—esophageal cancer	0.000185	0.00107	CcSEcCtD
Ifosfamide—Decreased appetite—Cisplatin—esophageal cancer	0.000181	0.00104	CcSEcCtD
Ifosfamide—Pneumonia—Methotrexate—esophageal cancer	0.00018	0.00104	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00018	0.00103	CcSEcCtD
Ifosfamide—Infestation NOS—Methotrexate—esophageal cancer	0.000179	0.00103	CcSEcCtD
Ifosfamide—Infestation—Methotrexate—esophageal cancer	0.000179	0.00103	CcSEcCtD
Ifosfamide—Pain—Cisplatin—esophageal cancer	0.000178	0.00102	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000177	0.00102	CcSEcCtD
Ifosfamide—Vision blurred—Capecitabine—esophageal cancer	0.000177	0.00102	CcSEcCtD
Ifosfamide—Renal failure—Methotrexate—esophageal cancer	0.000176	0.00101	CcSEcCtD
Ifosfamide—Stomatitis—Methotrexate—esophageal cancer	0.000174	0.001	CcSEcCtD
Ifosfamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000174	0.001	CcSEcCtD
Ifosfamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000174	0.001	CcSEcCtD
Ifosfamide—Anaemia—Capecitabine—esophageal cancer	0.000174	0.001	CcSEcCtD
Ifosfamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000171	0.000987	CcSEcCtD
Ifosfamide—Haematuria—Methotrexate—esophageal cancer	0.000171	0.000983	CcSEcCtD
Ifosfamide—Malaise—Capecitabine—esophageal cancer	0.000169	0.000976	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000169	0.000975	CcSEcCtD
Ifosfamide—Vertigo—Capecitabine—esophageal cancer	0.000169	0.000972	CcSEcCtD
Ifosfamide—Leukopenia—Capecitabine—esophageal cancer	0.000168	0.000969	CcSEcCtD
Ifosfamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000167	0.000962	CcSEcCtD
Ifosfamide—Palpitations—Capecitabine—esophageal cancer	0.000166	0.000956	CcSEcCtD
Ifosfamide—Body temperature increased—Cisplatin—esophageal cancer	0.000164	0.000947	CcSEcCtD
Ifosfamide—Cough—Capecitabine—esophageal cancer	0.000164	0.000944	CcSEcCtD
Ifosfamide—Hypertension—Capecitabine—esophageal cancer	0.000162	0.000934	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—esophageal cancer	0.000162	0.00093	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—esophageal cancer	0.000161	0.000925	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—esophageal cancer	0.000161	0.000925	CcSEcCtD
Ifosfamide—Chest pain—Capecitabine—esophageal cancer	0.00016	0.000921	CcSEcCtD
Ifosfamide—Myalgia—Capecitabine—esophageal cancer	0.00016	0.000921	CcSEcCtD
Ifosfamide—Arthralgia—Capecitabine—esophageal cancer	0.00016	0.000921	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000159	0.000915	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000159	0.000914	CcSEcCtD
Ifosfamide—Discomfort—Capecitabine—esophageal cancer	0.000158	0.00091	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—esophageal cancer	0.000158	0.000907	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—esophageal cancer	0.000155	0.000892	CcSEcCtD
Ifosfamide—Confusional state—Capecitabine—esophageal cancer	0.000155	0.00089	CcSEcCtD
Ifosfamide—Oedema—Capecitabine—esophageal cancer	0.000153	0.000883	CcSEcCtD
Ifosfamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000153	0.000883	CcSEcCtD
Ifosfamide—Infection—Capecitabine—esophageal cancer	0.000152	0.000877	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000152	0.000875	CcSEcCtD
Ifosfamide—Nervous system disorder—Capecitabine—esophageal cancer	0.00015	0.000866	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—esophageal cancer	0.00015	0.000865	CcSEcCtD
Ifosfamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00015	0.000865	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—esophageal cancer	0.00015	0.000863	CcSEcCtD
Ifosfamide—Asthenia—Cisplatin—esophageal cancer	0.000149	0.000859	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—esophageal cancer	0.000149	0.000859	CcSEcCtD
Ifosfamide—Skin disorder—Capecitabine—esophageal cancer	0.000149	0.000858	CcSEcCtD
Ifosfamide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000148	0.000854	CcSEcCtD
Ifosfamide—Anorexia—Capecitabine—esophageal cancer	0.000146	0.000842	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—esophageal cancer	0.000146	0.000839	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—esophageal cancer	0.000145	0.000836	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—esophageal cancer	0.000145	0.000834	CcSEcCtD
Ifosfamide—Chills—Methotrexate—esophageal cancer	0.000144	0.00083	CcSEcCtD
Ifosfamide—Hypotension—Capecitabine—esophageal cancer	0.000143	0.000825	CcSEcCtD
Ifosfamide—Diarrhoea—Cisplatin—esophageal cancer	0.000142	0.00082	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—esophageal cancer	0.000142	0.000818	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—esophageal cancer	0.000141	0.000811	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—esophageal cancer	0.00014	0.000805	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—esophageal cancer	0.00014	0.000805	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00014	0.000805	CcSEcCtD
Ifosfamide—Paraesthesia—Capecitabine—esophageal cancer	0.000138	0.000793	CcSEcCtD
Ifosfamide—Dyspnoea—Capecitabine—esophageal cancer	0.000137	0.000787	CcSEcCtD
Ifosfamide—Decreased appetite—Capecitabine—esophageal cancer	0.000133	0.000768	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000132	0.000762	CcSEcCtD
Ifosfamide—Vomiting—Cisplatin—esophageal cancer	0.000132	0.000762	CcSEcCtD
Ifosfamide—Fatigue—Capecitabine—esophageal cancer	0.000132	0.000761	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—esophageal cancer	0.000132	0.000759	CcSEcCtD
Ifosfamide—Rash—Cisplatin—esophageal cancer	0.000131	0.000755	CcSEcCtD
Ifosfamide—Pain—Capecitabine—esophageal cancer	0.000131	0.000755	CcSEcCtD
Ifosfamide—Constipation—Capecitabine—esophageal cancer	0.000131	0.000755	CcSEcCtD
Ifosfamide—Dermatitis—Cisplatin—esophageal cancer	0.000131	0.000755	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00013	0.000747	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—esophageal cancer	0.000129	0.000744	CcSEcCtD
Ifosfamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000126	0.000728	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—esophageal cancer	0.000126	0.000726	CcSEcCtD
Ifosfamide—Vertigo—Methotrexate—esophageal cancer	0.000126	0.000724	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000125	0.000722	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—esophageal cancer	0.000125	0.000721	CcSEcCtD
Ifosfamide—Nausea—Cisplatin—esophageal cancer	0.000124	0.000712	CcSEcCtD
Ifosfamide—Cough—Methotrexate—esophageal cancer	0.000122	0.000703	CcSEcCtD
Ifosfamide—Urticaria—Capecitabine—esophageal cancer	0.000122	0.000702	CcSEcCtD
Ifosfamide—Abdominal pain—Capecitabine—esophageal cancer	0.000121	0.000698	CcSEcCtD
Ifosfamide—Body temperature increased—Capecitabine—esophageal cancer	0.000121	0.000698	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—esophageal cancer	0.000121	0.000698	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—esophageal cancer	0.000119	0.000686	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—esophageal cancer	0.000119	0.000686	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—esophageal cancer	0.000119	0.000686	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000118	0.000681	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—esophageal cancer	0.000118	0.000678	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—esophageal cancer	0.000115	0.000663	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000114	0.000657	CcSEcCtD
Ifosfamide—Infection—Methotrexate—esophageal cancer	0.000113	0.000653	CcSEcCtD
Ifosfamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000113	0.000651	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—esophageal cancer	0.000112	0.000645	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000112	0.000644	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—esophageal cancer	0.000111	0.000639	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—esophageal cancer	0.00011	0.000635	CcSEcCtD
Ifosfamide—Asthenia—Capecitabine—esophageal cancer	0.00011	0.000634	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—esophageal cancer	0.000109	0.000627	CcSEcCtD
Ifosfamide—Pruritus—Capecitabine—esophageal cancer	0.000109	0.000625	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—esophageal cancer	0.000107	0.000614	CcSEcCtD
Ifosfamide—Diarrhoea—Capecitabine—esophageal cancer	0.000105	0.000604	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000104	0.000599	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—esophageal cancer	0.000103	0.00059	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—esophageal cancer	0.000102	0.000586	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—esophageal cancer	0.000101	0.000584	CcSEcCtD
Ifosfamide—Dizziness—Capecitabine—esophageal cancer	0.000101	0.000584	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—esophageal cancer	9.92e-05	0.000571	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.86e-05	0.000568	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—esophageal cancer	9.84e-05	0.000567	CcSEcCtD
Ifosfamide—Pain—Methotrexate—esophageal cancer	9.76e-05	0.000562	CcSEcCtD
Ifosfamide—Vomiting—Capecitabine—esophageal cancer	9.75e-05	0.000561	CcSEcCtD
Ifosfamide—Rash—Capecitabine—esophageal cancer	9.67e-05	0.000557	CcSEcCtD
Ifosfamide—Dermatitis—Capecitabine—esophageal cancer	9.66e-05	0.000556	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—esophageal cancer	9.41e-05	0.000542	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—esophageal cancer	9.34e-05	0.000538	CcSEcCtD
Ifosfamide—Nausea—Capecitabine—esophageal cancer	9.11e-05	0.000525	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—esophageal cancer	9.07e-05	0.000522	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—esophageal cancer	9.02e-05	0.00052	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—esophageal cancer	9.02e-05	0.00052	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—esophageal cancer	8.41e-05	0.000484	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—esophageal cancer	8.19e-05	0.000472	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—esophageal cancer	8.08e-05	0.000465	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—esophageal cancer	7.81e-05	0.00045	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—esophageal cancer	7.55e-05	0.000435	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—esophageal cancer	7.26e-05	0.000418	CcSEcCtD
Ifosfamide—Rash—Methotrexate—esophageal cancer	7.2e-05	0.000414	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—esophageal cancer	7.19e-05	0.000414	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—esophageal cancer	6.78e-05	0.00039	CcSEcCtD
Ifosfamide—PTGS1—Metabolism—GNG7—esophageal cancer	2.32e-05	0.000226	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CRABP1—esophageal cancer	2.31e-05	0.000224	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ADH1B—esophageal cancer	2.3e-05	0.000224	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.29e-05	0.000223	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.27e-05	0.000221	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ADH7—esophageal cancer	2.27e-05	0.000221	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TYMP—esophageal cancer	2.25e-05	0.000219	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.25e-05	0.000219	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALDH2—esophageal cancer	2.24e-05	0.000218	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TYMP—esophageal cancer	2.2e-05	0.000214	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GNG7—esophageal cancer	2.2e-05	0.000214	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—HMOX1—esophageal cancer	2.2e-05	0.000213	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP26A1—esophageal cancer	2.19e-05	0.000213	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CA2—esophageal cancer	2.18e-05	0.000212	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CA1—esophageal cancer	2.18e-05	0.000212	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.18e-05	0.000212	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALDH2—esophageal cancer	2.18e-05	0.000212	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP26A1—esophageal cancer	2.14e-05	0.000208	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000208	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.13e-05	0.000208	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALOX15—esophageal cancer	2.13e-05	0.000208	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.000205	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ABCB1—esophageal cancer	2.11e-05	0.000205	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALOX15—esophageal cancer	2.09e-05	0.000203	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTT1—esophageal cancer	2.07e-05	0.000201	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.06e-05	0.0002	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP2A6—esophageal cancer	2.05e-05	0.000199	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.04e-05	0.000198	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTO1—esophageal cancer	2.04e-05	0.000198	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TPI1—esophageal cancer	2.04e-05	0.000198	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADH7—esophageal cancer	2.03e-05	0.000197	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.03e-05	0.000197	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.01e-05	0.000195	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ENO1—esophageal cancer	2e-05	0.000195	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS1—esophageal cancer	2e-05	0.000195	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.99e-05	0.000194	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CA2—esophageal cancer	1.99e-05	0.000194	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TPI1—esophageal cancer	1.99e-05	0.000194	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTO1—esophageal cancer	1.99e-05	0.000194	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000192	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000192	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTT1—esophageal cancer	1.96e-05	0.00019	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALDOB—esophageal cancer	1.95e-05	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.95e-05	0.000189	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ENO1—esophageal cancer	1.94e-05	0.000189	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PSME2—esophageal cancer	1.91e-05	0.000186	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PSME1—esophageal cancer	1.91e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALDOB—esophageal cancer	1.91e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TYMP—esophageal cancer	1.91e-05	0.000185	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.88e-05	0.000183	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.86e-05	0.000181	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.85e-05	0.00018	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADH7—esophageal cancer	1.85e-05	0.00018	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.85e-05	0.00018	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.84e-05	0.000179	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ENO1—esophageal cancer	1.83e-05	0.000178	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS1—esophageal cancer	1.83e-05	0.000178	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.83e-05	0.000178	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.82e-05	0.000177	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.81e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PSME1—esophageal cancer	1.81e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PSME2—esophageal cancer	1.81e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.78e-05	0.000173	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GNG7—esophageal cancer	1.77e-05	0.000172	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GNG7—esophageal cancer	1.73e-05	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TPI1—esophageal cancer	1.72e-05	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.72e-05	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TYMP—esophageal cancer	1.7e-05	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.7e-05	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.69e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.69e-05	0.000164	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.67e-05	0.000162	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.66e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.66e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.65e-05	0.000161	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.65e-05	0.00016	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.62e-05	0.000158	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.62e-05	0.000158	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.61e-05	0.000157	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.6e-05	0.000156	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.59e-05	0.000155	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.58e-05	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.58e-05	0.000153	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.56e-05	0.000152	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.56e-05	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TYMP—esophageal cancer	1.55e-05	0.000151	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.55e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.54e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.54e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TPI1—esophageal cancer	1.54e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.53e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.51e-05	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GNG7—esophageal cancer	1.5e-05	0.000146	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.48e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ENO1—esophageal cancer	1.48e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.48e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.47e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.47e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.46e-05	0.000142	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PSME2—esophageal cancer	1.46e-05	0.000142	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PSME1—esophageal cancer	1.46e-05	0.000142	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.45e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ENO1—esophageal cancer	1.45e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.44e-05	0.00014	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.44e-05	0.00014	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PSME2—esophageal cancer	1.43e-05	0.000139	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PSME1—esophageal cancer	1.43e-05	0.000139	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.42e-05	0.000138	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—HMOX1—esophageal cancer	1.41e-05	0.000138	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CREBBP—esophageal cancer	1.41e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.41e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.41e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TPI1—esophageal cancer	1.4e-05	0.000136	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.4e-05	0.000136	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.4e-05	0.000136	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.39e-05	0.000135	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ABCB1—esophageal cancer	1.36e-05	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.35e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GNG7—esophageal cancer	1.34e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.34e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.34e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.32e-05	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.32e-05	0.000128	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.31e-05	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.29e-05	0.000126	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.28e-05	0.000125	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.28e-05	0.000125	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NOS3—esophageal cancer	1.26e-05	0.000123	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.26e-05	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.25e-05	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ENO1—esophageal cancer	1.25e-05	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.25e-05	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PSME1—esophageal cancer	1.23e-05	0.00012	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PSME2—esophageal cancer	1.23e-05	0.00012	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.23e-05	0.00012	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.22e-05	0.000119	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADH7—esophageal cancer	1.22e-05	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GNG7—esophageal cancer	1.22e-05	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.19e-05	0.000116	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.18e-05	0.000115	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.18e-05	0.000115	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.17e-05	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.16e-05	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—esophageal cancer	1.15e-05	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.14e-05	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ENO1—esophageal cancer	1.12e-05	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.12e-05	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSME1—esophageal cancer	1.1e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSME2—esophageal cancer	1.1e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.09e-05	0.000106	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.08e-05	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.08e-05	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.08e-05	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.07e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.07e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.07e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.06e-05	0.000103	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.04e-05	0.000101	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.03e-05	9.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TYMP—esophageal cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ENO1—esophageal cancer	1.02e-05	9.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.02e-05	9.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.01e-05	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSME2—esophageal cancer	1e-05	9.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSME1—esophageal cancer	1e-05	9.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1e-05	9.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.95e-06	9.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.7e-06	9.43e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.62e-06	9.36e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—EP300—esophageal cancer	9.59e-06	9.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	9.51e-06	9.24e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CREBBP—esophageal cancer	9.36e-06	9.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TPI1—esophageal cancer	9.25e-06	9e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.25e-06	9e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.14e-06	8.89e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CREBBP—esophageal cancer	9.08e-06	8.82e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.96e-06	8.72e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	8.94e-06	8.69e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.87e-06	8.63e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.77e-06	8.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.77e-06	8.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.67e-06	8.43e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CREBBP—esophageal cancer	8.58e-06	8.34e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.54e-06	8.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.46e-06	8.23e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NOS3—esophageal cancer	8.38e-06	8.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMOX1—esophageal cancer	8.16e-06	7.93e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.15e-06	7.93e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NOS3—esophageal cancer	8.13e-06	7.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNG7—esophageal cancer	8.05e-06	7.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8e-06	7.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCB1—esophageal cancer	7.83e-06	7.61e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NOS3—esophageal cancer	7.68e-06	7.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—esophageal cancer	7.67e-06	7.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.54e-06	7.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.44e-06	7.23e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—esophageal cancer	7.43e-06	7.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.3e-06	7.09e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.18e-06	6.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.14e-06	6.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—esophageal cancer	7.1e-06	6.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.09e-06	6.9e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—esophageal cancer	7.03e-06	6.83e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CREBBP—esophageal cancer	6.92e-06	6.73e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CREBBP—esophageal cancer	6.77e-06	6.58e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ENO1—esophageal cancer	6.72e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.72e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.63e-06	6.45e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSME2—esophageal cancer	6.63e-06	6.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSME1—esophageal cancer	6.63e-06	6.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—EP300—esophageal cancer	6.38e-06	6.2e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NOS3—esophageal cancer	6.2e-06	6.03e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—EP300—esophageal cancer	6.18e-06	6.01e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NOS3—esophageal cancer	6.06e-06	5.89e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.92e-06	5.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.86e-06	5.7e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—EP300—esophageal cancer	5.84e-06	5.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.72e-06	5.56e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—esophageal cancer	5.67e-06	5.51e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.54e-06	5.39e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.4e-06	5.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.37e-06	5.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NOS3—esophageal cancer	5.25e-06	5.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.23e-06	5.09e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.9e-06	4.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.8e-06	4.67e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.77e-06	4.64e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—esophageal cancer	4.72e-06	4.59e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—EP300—esophageal cancer	4.72e-06	4.59e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.71e-06	4.58e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NOS3—esophageal cancer	4.68e-06	4.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—EP300—esophageal cancer	4.61e-06	4.48e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—esophageal cancer	4.57e-06	4.45e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—esophageal cancer	4.32e-06	4.2e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.28e-06	4.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NOS3—esophageal cancer	4.27e-06	4.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—EP300—esophageal cancer	3.99e-06	3.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.91e-06	3.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—EP300—esophageal cancer	3.56e-06	3.47e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.49e-06	3.39e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.41e-06	3.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—EP300—esophageal cancer	3.25e-06	3.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.15e-06	3.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.95e-06	2.87e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.82e-06	2.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.64e-06	2.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.58e-06	2.51e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.4e-06	2.34e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EP300—esophageal cancer	2.14e-06	2.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.59e-06	1.54e-05	CbGpPWpGaD
